US Patent 7342125 Method of treating inflammation with acanthoic acid derivatives
Patent 7342125 was granted and assigned to Nereus Pharmaceuticals on March, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Emmanuel A. Theodorakis0
Michael Palladino0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+284 characters)
Article
Patent abstract
Novel compounds are disclosed that have the chemical structure of Formula (II), and its prodrug esters and acid-addition salts, and that are useful as Interleukin-1 and Tumor Necrosis Factor-α modulators, and thus are useful in the treatment of various listed diseases.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07342125 Method of treating inflammation with acanthoic acid derivatives US Patent 7342125 Method of treating inflammation with acanthoic acid derivatives
Infobox
Patent Number
07342125
Patent Number
7342125
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07342125 Method of treating inflammation with acanthoic acid derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07342125
Date of patent
March 11, 2008
Patent application number
11108941
Date Filed
April 19, 2005
Patent primary examiner
Find more entities like US Patent 7342125 Method of treating inflammation with acanthoic acid derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
